Quantcast
Channel: Endpoints News
Browsing all 2658 articles
Browse latest View live

Roche separates CFO, informatics posts; Lilly execs land at Kailera, Neurocrine

→ Wafaa Mamilli’s first day as chief digital technology officer for Roche will be Feb. 10, according to a release on the eve of the Swiss pharma’s

View Article


AbbVie raises Skyrizi and Rinvoq estimates, predicts $31B in 2027 sales

The loss of Humira exclusivity was long expected to be a blow to AbbVie’s immunology dominance, but the Skyrizi-Rinvoq tandem keeps outpacing expectations. In its fourth-quarter and full-year 2024...

View Article


Celltrion looks to buy US facilities to sidestep potential Trump tariffs 

South Korean biopharma contract manufacturer Celltrion is considering acquiring US manufacturing sites to mitigate President Donald Trump’s potential tariffs on foreign-made pharmaceuticals. Trump is...

View Article

Daiichi Sankyo taps new CEO, aims to build up ADC franchise

Daiichi Sankyo promoted Hiroyuki Okuzawa to CEO, and he will take over from Sunao Manabe on April 1. Okuzawa is currently Daiichi’s chief operating officer. Before starting that role in 2023 ...

View Article

AstraZeneca scraps plan to expand UK vaccine site

AstraZeneca has canceled its plans to expand its vaccine manufacturing site in Speke, UK, after the new UK government trimmed funding for the project, a company spokesperson confirmed to Endpoints...

View Article


England agrees to pay for Vertex’s sickle cell disease gene therapy

Vertex Pharmaceuticals and the National Health Service in England have reached a payment deal making the gene-edited therapy Casgevy available to certain people with sickle cell disease. The NHS said...

View Article

Genentech joins suits against STD clinics over 340B discounts

Genentech is the latest drugmaker to sue the federal government over STD clinics it says are wrongfully receiving discounts through the federal 340B program. The company claimed Friday that several...

View Article

AbbVie executives bask in Skyrizi, Rinvoq successes as the drugs take up...

The reports of AbbVie’s demise have been greatly exaggerated. Gone are the worries of Humira competition and its monumental patent cliff. The “lack of a shiny object” in the pipeline is a ...

View Article


RFK Jr. continues to evade questions on vaccines and autism

Robert F. Kennedy Jr.’s chances of becoming HHS chief likely hinge on one of his more controversial stances: that vaccines contribute to the development of autism. And in written responses to ...

View Article


RFK Jr. hearings leave key GOP senator “struggling”; Drugmakers report Q4...

Welcome back to Endpoints Weekly, thanks for starting your weekend with us. This week’s news was dominated by Robert F. Kennedy Jr.’s confirmation hearings to be HHS Secretary, as Kennedy faced two...

View Article

Thermo Fisher to lay off 300 workers at two viral vector factories  

Thermo Fisher Scientific is cutting 300 employees across two viral vector manufacturing facilities in Massachusetts, marking the second round of layoffs at those factories in the past few months. The...

View Article

Senate Democrats criticize RFK Jr.'s divestment plans ahead of Tuesday vote

Democrats in the Senate Finance Committee are calling Robert F. Kennedy Jr.'s new divestment plans to his son "plainly inadequate" ahead of a Tuesday vote on whether to advance his nomination to lead...

View Article

Charles River to shut down North Carolina pathology facility

Charles River Laboratories is permanently closing its pathology facility in Durham, NC, after determining it is no longer “a strategic fit,” a company spokesperson told Endpoints News in an email....

View Article


Biogen's research chief talks China, neuropsychiatry and pipeline plan

Fresh off a reorganization, Biogen’s research leader Jane Grogan says the biotech has to “look outside the walls of the company” to avoid being left behind. In her first interview since then, she told ...

View Article

Noom cuts coaches, staff as fewer sign up

Noom has laid off employees in coaching and customer service after its bet on prescribing GLP-1 drugs wasn't enough to offset losses from its original program, Endpoints News has learned. The job cuts...

View Article


US biosimilar 'void' spells trouble as biologic patent expirations loom,...

While 118 biologics are expected to lose patent protection in the US over the next decade, that $234 billion opportunity for biosimilar developers may not materialize because of several challenges,...

View Article

Gene-edited pig kidneys will be tested in more humans soon

The FDA has cleared two new requests to test gene-edited pig kidney transplantation, including a first clinical trial of the technology. United Therapeutics announced Monday that it received the...

View Article


Omega Therapeutics nears bankruptcy filing, lays off workers

Omega Therapeutics anticipates filing for bankruptcy within the next week, the epigenomic medicines company said in a filing, a sudden end for a company that just a year ago signed an obesity...

View Article

Merck pauses Gardasil shipments to China

Merck is pausing HPV vaccine shipments to China “until at least mid-year” as it grapples with lower demand for the shot. The company also withdrew its $11 billion sales target for Gardasil by 2030 as ...

View Article

Astellas shakes up management despite impressive nine-month earnings

Astellas is reorganizing its management team, and while it doesn't involve a change at the top as Daiichi Sankyo announced last week, it could still have major repercussions for drug development at ...

View Article
Browsing all 2658 articles
Browse latest View live